Although many traditional therapies areavailable for genital warts(GW), one of the major problemsin the treatment of GW is a high recurrenence rate. Inorder to resolve the problem of recurrence, new theraputicapproaches have been investigated. New approaches beingexplored include 5-fiuorouracil/epinephrine injectablecollagen gel, 5% imiguimod cream and humanpapillomavirus vaccine. Fluorouracil /epinephrine injectable collagen gel achieves high concentration of fiuorouracilat the site of injection. Imiguimod is a novelimmune-respones modifier, giving good clearance rates andtolerable side effects. Although the use of an HPV vaccine isfar away, preliminary studies show that it may be possibleto develop suitable prophylactic and therapeutic vaccines togenital warts.